Roundtable_2015 - Center for Healthcare Innovation

Understanding Value in a ConsumerOriented, Patient-Centric Era
An Executive Roundtable Discussion
Thursday, October 15, 2015 | 1:00PM - 5:00PM EST
Edelman | 250 Hudson Street | New York, NY, USA 10013
ORGANIZATIONS REPRESENTED
Allscripts
American Brain Tumor Association
American MedChem Nonprofit Corporation
Americas Health Foundation
Bayer Healthcare
Catalent Pharma Solutions
Center for Healthcare Innovation
Cleveland Clinic
Curant Health
Cystic Fibrosis Foundation
Dohmen Life Science Services
FedEx Services
Fordham University
GE Healthcare
GPIC
Hoboken University Medical Center
Insight Consulting Group
Life Science Leader Magazine
Medgenics
National Osteoporosis Foundation
Openbox
Pall Corporation
Parkland Health & Hospital System
Pfizer
Press Ganey Associates
Quintiles Advisory Services
Spark Therapeutics
Teva Pharmaceuticals
Upsher-Smith Laboratories
WellDoc
2 Understanding Healthcare Value in a Consumer-Oriented, Patient-Centric Era Roundtable
Understanding Value in a Consumer-Oriented,
Patient-Centric Era Executive Roundtable
Thursday, October 15, 2015
1:00PM - 5:00PM EST
Edelman
250 Hudson Street
New York, NY, USA 10013
Understanding What Patient-Centric
Healthcare Value Really Means
Dear Executive Roundtable Attendees,
On behalf of the Center for Healthcare Innovation (CHI), we welcome you to
the Understanding Value in a Consumer-Oriented, Patient-Centric Era
Roundtable. Today’s Roundtable is an exclusive discussion bringing together the top thought-leaders, visionaries, and executives from the patient advocate, provider, payer, pharma, biotech, and device sectors to discuss and
increase understanding of what patient-centric healthcare value means in
the 21st century.
The healthcare landscape has rapidly shifted towards a consumer-driven,
patient-centric model of care delivery. Today’s patients have become more
empowered in their health and well-being, better informed, and more financially invested than ever before. This paradigm shift has dramatic implications not only for patients, but also for industry as these latter groups attempt to define and deliver patient-centric healthcare value. Furthermore,
the Roundtable explores the relationship between the definition of value,
quality, access, and cost issues. As healthcare costs continue to rise, capitation payment models become the new norm, and incentives shift as a result of moving to a value-based healthcare system, understanding and integrating patient-centricity into healthcare value will become more important
than ever.
We thank you all for joining today’s discussion. We wish you an informative
and productive afternoon of learning, and hope you learn new, actionable
ideas about patient-centricity that you can take back to your organizations.
Kindest Regards,
Joseph P. Gaspero
President & Co-Founder
Center for Healthcare Innovation
222 S. Riverside Plaza (Suite 1900)
|
Chicago, IL 60606
|
chisite.org
|
[email protected]
PRESENTED BY
Center for Healthcare Innovation
CHI is an independent, 501(c)(3) research
and educational institute that helps patients and providers increase their
knowledge and understanding of the opportunities and challenges of maximizing
healthcare value to improve health and
quality of life. We aim to make the world
a healthier place. CHI encourages and
enables meaningful and executable innovation that aims to address existing and
ensuing healthcare dynamics through
communication, education, training, symposia, reports, and research. By bringing
the best and brightest healthcare leaders
from all over the world together to share
their ideas and expertise, CHI creates a
unique opportunity to address and improve healthcare value, which we view as
a function of quality, access, and cost.
Agenda
1:00PM
Registration & Networking
1:30PM
Opening Remarks: Joff Masukawa
1:35PM
1st Roundtable Session
Co-Moderators: Dennis Urbaniak & Rob Wright
3:00PM
Coffee Break & Networking
3:30PM
2nd Roundtable Session
Co-Moderators: Dennis Urbaniak & Rob Wright
4:45PM
Closing Remarks: Mr. Joff Masukawa
4 Understanding Healthcare Value in a Consumer-Oriented, Patient-Centric Era Roundtable
Co-Moderators
Mr. Dennis Urbaniak is a Managing Director at Accenture. He is a life science
and healthcare executive who has demonstrated leadership in driving innovative,
customer-centric approaches that result in tangible business results. His areas of
expertise include population health, patient services, change management, innovation process, executive leadership, customer-centric marketing and sales, and performance management. Mr. Urbaniak is also the Chairman and a member of the
Center for Healthcare Innovation’s Executive Council since its inception in 2009.
Mr. Dennis Urbaniak,
Managing Director,
Accenture
Mr. Rob Wright,
Chief Editor,
Life Science
Leader Magazine
Mr. Rob Wright is the Chief Editor of Life Science Leader Magazine. Prior to joining the publication in this role in 2010, Wright spent nearly 20 years in the pharmaceutical industry. His experience with companies such as Mead Johnson Nutritionals
(formerly a division of Bristol-Myers Squibb), Organon Pharmaceuticals, ScheringPlough, and Merck helps him to provide his readers with credible insights. During his
industry career, Wright conducted well over 1,000 presentations and roundtable discussions, including the facilitation of FDA-mandated clinical training programs for
hundreds of licensed healthcare providers. He has chaired, co-chaired, moderated
and served as a speaker at industry and academic conferences. Wright’s 100+ published articles have appeared in peer-reviewed academic journals, B2B magazines
and online publications. He received a Bachelor of Science (B.S.) in Business Administration from Indiana University of Pennsylvania, Indiana, PA, and a Master of
Business Administration (MBA) with distinction from Gannon University, Erie, PA. He
completed his doctoral coursework in marketing at Cleveland State University,
Cleveland, OH. During his academic career he was selected as a member of Sigma
Beta Delta (International Honor Society for Business, Management, and Administration) and Beta Gamma Sigma (International Honor Society for AACSB accredited
business program).
Opening & Closing Remarks
Mr. Joff Masukawa,
Board Member,
Center for Healthcare
Innovation
Mr. Joff Masukawa is President of Diligentia, which develops core business strategies, product value, and tactical commercialization requirements for orphan drugs,
gene therapy, specialty pharmaceuticals, cell therapy, devices, diagnostics and other
novel emerging healthcare products and services. Prior to founding his independent
strategic advisory, Joff was Vice President and Global Head of Government Relations
and Public Affairs at Shire, where he designed and led strategies to build the company’s brand, leadership and engagement with governments, patients, payers and other
key external stakeholders in existing and emerging markets. Joff has held leadership
roles across commercial functions including market access, pricing and reimbursement, advocacy and government affairs, patient and provider services, and sales and
marketing at Shire, Genzyme, Visible Genetics, Gentiva and LabCorp. He has led and
executed many launch strategies for first-in-class products and services and is an expert at enabling optimal legislative, regulatory and market access environments to support business objectives. He began as a clinical sales representative for Merck. Joff is
a member of the Board of Directors of the Center for Healthcare Innovation, and a
member of the executive committee of the national chapter of the Society of Physician
Entrepreneurs.
Understanding Healthcare Value in a Consumer-Oriented, Patient-Centric Era Roundtable 5
Executive Participants
Mr. Scott Applebaum, JD
Chief Legal Officer
Medgenics
Dr. Anand Iyer, PhD, MBA
Chief Data Science Officer
WellDoc
Mr. Jerry Beyl
Vice President of Healthcare Sales
FedEx
Ms. Theresa Johnson, MBA, MA
Administrator Service Excellence
Parkland Health & Hospital System
Dr. Kristine Bordenave, MD
Lead Medical Director
Humana
Mr. Carmen Kestranek, MBA
Senior Director, Office of Patient Experience
Cleveland Clinic
Ms. Patricia Cmielewski, MBA
Chief Marketing Officer
Press Ganey Associates
Dr. Rivka Kreitman, PhD, MA
SVP, Head of Biologics, Women Health &
Autoimmune Global Strategic Marketing
Teva Pharmaceuticals
Mr. Robert Coull
Managing Director
GPIC
Dr. John Doyle, DrPH
Senior Vice President and Managing Director
Quintiles Advisory Services
Ms. Mirona Dragnea, JD
Director, Law & Public Policy
Americas Health Foundation
Mr. Patrick Dunham
President & CEO
Curant Health
Dr. Lisa Feng, DrPH, MPH
Senior Director, Access Policy + Innovation
Cystic Fibrosis Foundation
Dr. Eric Floyd, PhD, MBA
Chief Scientific Officer
Dohmen Life Science Services
Dr. Gregory Gilmet, MD, MPH
Vice President, Medical and Scientific Affairs
Upsher-Smith Laboratories
Ms. Therese Little
Director
Openbox
Mr. Jeffrey Marrazzo, MBA, MPA
Co-Founder, CEO and Director
Spark Therapeutics
Mr. Jerold Martin, MS
Senior Vice President of Global
Scientific Affairs
Pall Corporation (Retired)
Ms. Neena Philip
Assistant Vice President of Nursing Services
Hoboken University Medical Center
Mr. Matt Portch
Senior Director, Commercial Effectiveness
Pfizer
Ms. Susan Randall, MSN
Senior Director, Science and Education
National Osteoporosis Foundation
6 Understanding Healthcare Value in a Consumer-Oriented, Patient-Centric Era Roundtable
Executive Participants
Ms. Patricia Riskind, MBA
Chief Client Experience Officer
Press Ganey Associates
Ms. Vera Rulon, MS
Board of Directors, American Health Information
Management Association Foundation
Director, Strategic Communications, External Medical
Communications, Pfizer Medical
Mr. Dick Salvatierra, MPA, MA
President
Americas Health Foundation
Dr. Roslyn Schneider, MD, MSc
Global Patient Affairs Lead
Pfizer
Dr. Robert Selliah, PhD
Founder, President & CEO
American MedChem Nonprofit Corporation
Dr. Falguni Sen, PhD
Professor
Fordham University
Dr. Cornell Stamoran
Vice President, Strategy & Government Affairs
Catalent Pharma Solutions
Dr. Tim Wighton, DrPH
Co-Founder & CEO
insight Communication
Ms. Elizabeth Wilson, MNA
President and CEO
American Brain Tumor Association
Mr. Don Woodlock
Senior Vice President and GM, Cardiology IT
GE Healthcare
Understanding Healthcare Value in a Consumer-Oriented, Patient-Centric Era Roundtable 7
CHI Roundtable Planning Committee
Dr. Cheryl Beal Anderson, PharmD, MBA
Vice-President, Head of Regulatory Affairs at Upsher-Smith Laboratories
Member of Board of Directors at CHI
Mr. Joseph Gaspero
President & Co-Founder of CHI
Ms. Lynn Hanessian
Chief Science Strategist at Edelman
Member of Board of Directors at CHI
Dr. Kevin Konradt
Project Manager at Allscripts
Mr. Joff Masukawa
President of Diligentia
Member of Board of Directors at CHI
Mr. Douglas Swill, JD
Partner & Chair of Health Care Practice Group at Drinker Biddle & Reath
Member of Board of Directors at CHI
Mr. Dennis Urbaniak
Managing Director at Accenture
Chairman of Executive Council at CHI
Dr. Eckhard von Keutz
Senior Vice President, Head Global Early Development at Bayer Healthcare
Member of Executive Council at CHI
8 Understanding Healthcare Value in a Consumer-Oriented, Patient-Centric Era Roundtable
MISSION
The Center for Healthcare Innovation is an independent, 501(c)(3) research and educational institute that helps patients
and providers increase their knowledge and understanding of the opportunities and challenges of maximizing healthcare
value to improve health and quality of life. We aim to make the world a healthier place. CHI encourages and enables
meaningful and executable innovation that aims to address existing and ensuing healthcare dynamics through communication, education, training, symposia, reports, and research. By bringing the best and brightest healthcare leaders
from all over the world together to share their ideas and expertise, CHI creates a unique opportunity to address and improve healthcare value, which we view as a function of quality, access, and cost.
OBJECTIVES
1. Bring together key stakeholders to develop collaborative relationships to positively impact healthcare value
2. Increase understanding of the definition, framework, and metrics of healthcare value
3. Produce primary, impactful research focused specifically on the interrelationship of healthcare
quality, access, & cost
4. Analyze fundamental drivers and trends of rapidly rising healthcare costs
5. Identify and disseminate best practices for optimizing healthcare quality and access
INITIATIVES
Diversity, Inclusion, & Life Sciences Symposium
Healthcare Executive Roundtable
Patient as an Innovator Educational Workshop
Healthcare Value and the Interrelationship of Quality, Access, and Costs Research Report
Pharmaceutical-ACO Collaboration Research Report
The Value of Sovaldi: Societal Cost Issues of New Interventions on Hepatitis C Research
Unintended Consequences of Healthcare & Life Science Legislation Research Report
Diversity & Inclusion Consulting
The Science Runway: Inspiring Young Girls to Join the Healthcare & Life Sciences Industry
Clinical Research Exchange
Understanding Healthcare Value in a Consumer-Oriented, Patient-Centric Era Roundtable 9
CHI LEADERSHIP
BOARD OF DIRECTORS
Mr. Michel Feldman (Chairman), JD, Senior Partner, Seyfarth Shaw
Dr. Cheryl Beal Anderson, PharmD, MBA, Vice-President, Head of Regulatory Affairs at Upsher-Smith
Dr. Benée Brown, PharmD, Senior Medical Science Liaison, Sanofi
Mr. Chris Caruso, MBA, Partner at Deloitte
Dr. James Gillespie, PhD, JD, MPA, Chief Executive Officer, Center for Healthcare Innovation
Mr. Sanjay Kadaveru, Founder and President, Action For India
Ms. Lynn Hanessian, Chief Science Strategist, Edelman
Mr. Joff Masukawa, President, Diligentia
Dr. Andrea Small-Howard, PhD, MBA, Chief Science Officer, GB Sciences
Mr. Douglas Swill, JD, Partner & Chair of Health Care Practice Group at Drinker Biddle & Reath
EXECUTIVE COUNCIL
Mr. Dennis Urbaniak (Chairman), Managing Director, Accenture
Dr. Laurent Audoly (Vice Chairman), Global Head R&D, Pierre Fabre
Dr. Albert Jaramillo, Managing Partner, Workplace International
Mr. Richard Smith, Managing Director, Life Sciences & Specialty Services, FedEx
Dr. Eckhard von Keutz, Senior Vice President, Head Global Early Development, Bayer Healthcare
RESEARCH GROUP
Mr. James Jordan (Chairman), Distinguished Service Professor in Healthcare & Biotechnology Management,
Carnegie Mellon University
Mr. Mark Kwatia (Vice Chairman), Cost Strategy, Abbott Laboratories
Dr. G. Randall Green, Program Director, Cardiac Surgery, St. Joseph’s Hospital Health Center
Dr. Marco Quarta, Director, Inst. for Bioengineering in Stem Cell & Regenerative Medicine, Stanford
Dr. Kate Rosenbluth, CEO, Cala Health
Dr. James Su, Chief Science Officer, Lap IQ
SPECIAL ADVISORS
Mr. Mark Hattas, Founder, Former CEO, & Chairman, Geneca
Dr. Stuart Rich, Professor of Medicine at Northwestern University
MANAGEMENT TEAM
Mr. Joseph Gaspero, President & Co-Founder, Center for Healthcare Innovation
Dr. Sarah Wamala, Swedish National Institute of Public Health
Dr. Tina Shah, Chair-Elect of Resident and Fellow Section, American Medical Association
Ms. Ritu Kamal, Global Project Manager, Biodesign Program, Stanford University
Mr. Joshua Limp, Senior Project Manager, Center for Healthcare Innovation
Ms. Sandra Mumanachit, Senior Consultant at CVS health
10 Understanding Healthcare Value in a Consumer-Oriented, Patient-Centric Era Roundtable
Upcoming Research & Education
The Patient as Innovator Educational Workshop
The Patient as Innovator workshop is an educational forum for patients, providers, payers, and policymakers to discuss innovative ways to create an earlier intersection between patients and developers of medical technologies in order to deliver a more
informed, value-driven approach to the innovation of new medical solutions, technologies, and treatments. In today’s healthcare
landscape, patients are dramatically more informed, empowered, and financially invested in their health and well-being than ever before. Technology has also made today’s patients as savvy and informed as ever. Additionally, providers, payers, and policymakers are faced with rising costs, increasing demand, and other pressures as healthcare transitions to a value-based system.
Thus, it is critical to engage key stakeholders and incorporate their perspectives earlier in development phases in order to ensure that provider organizations deliver healthcare products that are producing maximum value and quality, increasing access,
and reducing costs for patients. The Patient as Innovator workshop educates patients, providers, payers, and policymakers on
how to create earlier collaboration and incorporate all perspectives into medical innovation.
February 3, 2016 | Washington, DC, USA
chisite.org/education/patient-educational-workshop
Pharmaceutical-ACO Collaboration Research Report
A comprehensive research report examining pharma-ACO collaboration. The U.S. spends more on healthcare than many other
industrialized nations while not necessarily matching quality. The ACOs that were created out of the Patient Protection and
Affordable Care Act (ACA) were introduced to improve access to quality care while simultaneously reducing costs. As pharma, providers, and other healthcare stakeholders move to a value-based system with an emphasis on driving value for the patient, new and innovative partnerships and collaboration will be more important that even. The research report aims to explore pharma-ACO collaboration and other innovative partnership models.
February 2016
chisite.org/research
Best Practices for Implementing Patient-Centric Strategies White Paper
A white paper that examines how to implement patient-centric strategies for providers, pharma, pharmacy, payer, policymakers, and other stakeholders. This white paper will feature actionable, pragmatic insights and best practices on how organizations can develop strategies and implement tactics on putting patients at the center of the healthcare equation. The white paper will also explore some of the challenges that organizations face in attempting to implement these ideas.
March 2016
chisite.org/research
Diversity, Inclusion, & Life Sciences Symposium
The Diversity, Inclusion, & Life Sciences Symposium is an annual, interactive, collaborative symposium for life sciences and
healthcare executives, entrepreneurs, policymakers, researchers, scientists, technologists, academics, and service providers to
discuss best practices as well as challenges and opportunities at the crucial interface of diversity, inclusion, and the life sciences
industry. The symposium is the world’s preeminent annual conference focused specifically on mutually beneficial collaborations
between the life sciences industry and diverse communities. Attendees will gain valuable contacts, connections, knowledge,
information, and insights.
June 22, 2016 | Chicago, IL, USA
chisite.org/education/diversity-symposium
Understanding Healthcare Value in a Consumer-Oriented, Patient-Centric Era Roundtable 11
Center for Healthcare Innovation
www.chisite.org